SMTL ID : 4nju.2 (1 other biounit)

Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with tipranavir

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-dimer

Ligands

1 x TPV: N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE(Non-covalent)

TPV.1: 26 residues within 4Å: Chain A: R.8, L.23, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.48, G.49, I.50, P.81, T.82 Chain B: R.8, L.23, D.25, G.27, A.28, V.32, G.48, G.49, I.50, P.81, T.82, I.84 16 PLIP interactions: 12 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:L.23, A:A.28, A:V.32, A:I.50, A:P.81, A:T.82, B:V.32, B:I.50, B:I.84 Hydrogen bonds: A:D.29, A:D.30, A:D.30, A:I.50, B:I.50 Water bridges: A:D.29, A:G.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yedidi, R.S. et al., A Conserved Hydrogen-Bonding Network of P2 bis-Tetrahydrofuran-Containing HIV-1 Protease Inhibitors (PIs) with a Protease Active-Site Amino Acid Backbone Aids in Their Activity against PI-Resistant HIV. Antimicrob.Agents Chemother. (2014)

Release Date

2014-04-02

Peptides

Protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Protease

Related Entries With Identical Sequence